<p>Transcriptomics-Based Characterization of the Toxicity of ZnO Nanoparticles Against Chronic Myeloid Leukemia Cells</p>

Abstract

Introduction: Zinc oxide nanoparticles (ZnO NPs) have recently attracted attention as potential anti-cancer agents. To the best of our knowledge, the toxicity of ZnO NPs against human chronic myeloid leukemia cells (K562 cell line) has not been studied using transcriptomics approach. Objective: The goals of this study were to evaluate the capability of ZnO NPs to induce apoptosis in human chronic myeloid leukemia cells (K562 cells) and to investigate the putative mechanisms of action. Methods: We used viability assay and flowcytometry coupled with Annexin V-FITC and propidium iodide to investigate the toxicity of ZnO NPs on K562 cells and normal peripheral blood mononuclear cells. Next we utilized a DNA microarray-based transcriptomics approach to characterize the ZnO NPs-induced changes in the transcriptome of K562 cells. Results: ZnO NPs exerted a selective toxicity (mainly by apoptosis) on the leukemic cells (p≤0.005) and altered their transcriptome; 429 differentially expressed genes (DEGs) with fold change (FC)≥4 and p≤0.008 with corrected p≤0.05 were identified in K562 cells post treatment with ZnO NPs. The over-expressed genes were implicated in "response to zinc", "response to toxic substance" and "negative regulation of growth" (corrected p≤0.05). In contrast, the repressed genes positively regulated "cell proliferation", "cell migration", "cell adhesion", "receptor signaling pathway via JAK-STAT" and "phosphatidylinositol 3-kinase signaling" (corrected p≤0.05). Lowering the FC to ≥1.5 with p≤0.05 and corrected p≤0.1 showed that ZnO NPs over-expressed the anti-oxidant defense system, drove K562 cells to undergo mitochondrial-dependent apoptosis, and targeted NF-κB pathway. Conclusion: Taken together, our findings support the earlier studies that reported anticancer activity of ZnO NPs and revealed possible molecular mechanisms employed by ZnO NPs to induce apoptosis in K562 cells.

RETRACTED ARTICLE: A stepwise-targeting strategy for the treatment of cerebral ischemic stroke

“…PC-12 cells were seeded at a density of 1 × 10 5 per well in 6-well and incubated overnight. H 2 O 2 solution (200 µM, 2 h), and free TPP-MLT and TGN/SHp/TPP-MLT micelles (TPP-MLT, 10 µM) were added respectively for further incubation for 12 h. Then, cells were collected, resuspended with PBS, incubated with annexin V-FITC/ propidium iodide [28], and analyzed by flow cytometer (Beckman Coulter, CytoFlex S).…”

Analysis of Nanotoxicity with Integrated Omics and Mechanobiology

“…In particular, microRNAs have drawn much attention as new candidate molecules for transcriptional analyses. Transcriptome has been analyzed commonly using two methods, DNA-microarray and Next-generation sequencing (NGS), which are the most recently developed techniques for analyzing gene expression levels [ 35 , 36 ]. Due to high-throughput data generation, transcriptomics has been applied to evaluate the nanotoxicity in cells treated with NPs, such as CuO NPs, nano-Ag (nAg), nano-TiO 2 (nTiO 2 ), nano-ZnO (nZnO), CdTe/CdS, quantum dots (QDs), and silica-coated magnetic nanoparticles containing rhodamine B isothiocyanate dye [MNPs@SiO 2 (RITC)] [ 21 , 35 , 37 , 38 , 39 , 40 ].…”

Tumor Microenvironment Responsive Pepper Mild Mottle Virus-Based Nanotubes for Targeted Delivery and Controlled Release of Paclitaxel

“…MCF-7 cells were seeded at a density of 1×10 5 per well in 6-well, and then incubated with FA@PMMoV@PTX nanotubes for 24 h, using free PTX and PMMoV@PTX nanotubes as a control. Cells were then collected, resuspended in PBS, incubated with annexin V-FITC/propidium iodide, and analyzed by flow cytometry ( Alsagaby et al, 2020 ).…”